Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.330
+0.030 (1.30%)
At close: Jun 9, 2026, 4:00 PM EDT
2.290
-0.040 (-1.72%)
After-hours: Jun 9, 2026, 6:10 PM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $36.05 million as of June 9, 2026. Its market cap has increased by 19.78% in one year.
Market Cap
36.05M
Enterprise Value
17.38M
1-Year Change
19.78%
Ranking
Category
Stock Price
$2.33
Market Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $36.05M, a decrease of -99.47%. That is a compound annual growth rate of -36.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 35.60M | -27.20% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RenovoRx | 39.94M |
| Atossa Therapeutics | 39.18M |
| Gossamer Bio | 38.87M |
| Plus Therapeutics | 38.06M |
| ABVC BioPharma | 33.86M |
| Actinium Pharmaceuticals | 33.05M |
| INmune Bio | 32.97M |
| NanoViricides | 32.58M |